URINE VANILLYLMANDELIC ACID CREATININE RATIO
URINE VANILLYLMANDELIC ACID CREATININE RATIO is the result of the Clinical Investigation which measures the PATIENT's urine Vanillylmandelic Acid (VMA) creatinine ratio, which is used to evaluate catecholamine production, for the diagnosis of pheochromocytoma and neuroblastoma and in confirmation of elevated catecholamine levels.
Format / Length
max n2.n1
Description
URINE VANILLYLMANDELIC ACID CREATININE RATIO is the same as attribute CLINICAL INVESTIGATION RESULT VALUE.
URINE VANILLYLMANDELIC ACID CREATININE RATIO is the result of the Clinical Investigation which measures the PATIENT's urine Vanillylmandelic Acid (VMA) creatinine ratio, which is used to evaluate catecholamine production, for the diagnosis of pheochromocytoma and neuroblastoma and in confirmation of elevated catecholamine levels.
The value is presented in the range 0.0 - 10.0.
Also Known As
This data element is also known by these names:
| Context | Alias |
|---|---|
| Plural | URINE VANILLYLMANDELIC ACID CREATININE RATIOS |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Set | Cancer Outcomes and Services Data Set - Children Teenagers and Young Adults | references in description URINE VANILLYLMANDELIC ACID CREATININE RATIO |
| XML Schema Constraint | Cancer Outcomes and Services Data Set XML Schema Constraints | references in description URINE VANILLYLMANDELIC ACID CREATININE RATIO |
| Data Element | URINE VANILLYLMANDELIC ACID CREATININE RATIO | references in description URINE VANILLYLMANDELIC ACID CREATININE RATIO |
